ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #14,710Hybrid

Xenobiotica

Acronym:txen
•
Abbreviation (ISO):XENOBIOTICA
•
Identifier (ISSN):0049-8254(Print)/1366-5928(Online)
•
Publisher:Informa Healthcare
Clarivate IF (2026)
1.5↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Xenobiotica

WoS Q4
01231.8620181.920191.920201.912021220221.820231.320241.220251.52026
Annual Impact Factor Metric
Current (2026):1.5
Scopus SJR & RankScopus Q3
0.381
#14,710

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
95

95 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate7.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
101articles/year
4.44% Gold OA•95.05% Original Research

Aims & Scope

Xenobiotica covers seven main areas, including:General Xenobiochemistry, including in vitro studies concerned with the metabolism, disposition and excretion of drugs, and other xenobiotics, as well as the structure, function and regulation of associated enzymesClinical Pharmacokinetics and Metabolism, covering the pharmacokinetics and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in manAnimal Pharmacokinetics and Metabolism, covering the pharmacokinetics, and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in animalsPharmacogenetics, defined as the identification and functional characterisation of polymorphic genes that encode xenobiotic metabolising enzymes and transporters that may result in altered enzymatic, cellular and clinical responses to xenobioticsMolecular Toxicology, concerning the mechanisms of toxicity and the study of toxicology of xenobiotics at the molecular levelXenobiotic Transporters, concerned with all aspects of the carrier proteins involved in the movement of xenobiotics into and out of cells, and their impact on pharmacokinetic behaviour in animals and manTopics in Xenobiochemistry, in the form of reviews and commentaries are primarily intended to be a critical analysis of the issue, wherein the author offers opinions on the relevance of data or of a particular experimental approach or methodology

Topics Covered (Recognized by AI)
BiologyChemistryMedicineBiochemistryInternal MedicineEndocrinologyOrganic ChemistryGeneticsPhysicsPharmacologyNuclear Magnetic ResonanceEnzymologyBioinformaticsPsychologyPsychiatry
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank286/356
IndexSCIE
JCRSCIE2026

TOXICOLOGY

Q4
Rank98/106
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank270/356
IndexSCIE
JCISCIE2026

TOXICOLOGY

Q4
Rank96/106
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.5
Articles / Year64
Total Citations19
2025
IF1.2
Articles / Year77
Total Citations121
2024
IF1.3
Articles / Year77
Total Citations274
2023
IF1.8
Articles / Year73
Total Citations322
2022
IF1.997
Articles / Year100
Total Citations512

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #14,710Scopus Q3SCImago Profile
Scopus Coverage:1971-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyEnvironmental ScienceMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.381

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.62

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,796 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations368
3-Year Documents252
Citable Documents250

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ3
Health, Toxicology and MutagenesisQ3
Medicine (miscellaneous)Q3
PharmacologyQ3
ToxicologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 7.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Xenobiotica (acronym: txen, abbr: XENOBIOTICA, ISSN: 0049-8254) is a peer-reviewed international scholarly journal in the field of Medicine, published by Informa Healthcare in England since 1971. The periodical holds a Journal Impact Factor (JIF) of 1.50, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.381 (Q3), an H-index of 95.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 101 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,796 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Informa Healthcare
Publication Language
English
Frequency
Monthly
Founding Year
1971
Indexing & Databases
SCIEScopusPubMed
Editorial Address
TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON, ENGLAND, OXON, OX14 4RN

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 263b807b-2fb8-4444-be0e-444ac070abc0
Database Updated: 2026-09-28